 Ltd. logo1.jpg){kind=logo}
Share the post "Gujarat Inject (Kerala) announces Q1 results: Profit Rises by 300% YoY"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 1877.27 % in the past year, decrease in net sales/revenue by -43.81 %.
- Profit over the Year and quarter: Significant improvement in profitability for Gujarat Inject (Kerala) Ltd.. Notable increase of 335.71 % in net profit Year to Year, Gujarat Inject (Kerala) Ltd.’s profitability increased by 221.05 % in this quarter.
- EPS over the Year and quarter: EPS increased by 33.33 % Year to Year. EPS increased by 166.67 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.154 Cr | Rs. 5.419 Cr | Rs. 3.045 Cr | -43.81 % | + 1877.27 % |
| Expenses | Rs. 0.12 Cr | Rs. 5.37 Cr | Rs. 2.88 Cr | -46.37 % | + 2300 % |
| Operating Profit | Rs. 0.03 Cr | Rs. 0.05 Cr | Rs. 0.17 Cr | + 240 % | + 466.67 % |
| OPM % | 19.48 % | 0.92 % | 5.58 % | + 4.66 % | -13.9 % |
| Other Income | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Profit before tax | Rs. 0.03 Cr | Rs. 0.05 Cr | Rs. 0.17 Cr | + 240 % | + 466.67 % |
| Tax % | 27.03 % | 15.22 % | 26.06 % | + 10.84 % | -0.97 % |
| Net Profit | Rs. 0.03 Cr | Rs. 0.04 Cr | Rs. 0.12 Cr | + 200 % | + 300 % |
| EPS in Rs | Rs. 0.06 | Rs. 0.03 | Rs. 0.08 | + 166.67 % | + 33.33 % |
Today, we’re looking at Gujarat Inject (Kerala) Ltd.’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 1877.27 %. However, it did see a marginal slip of -43.81 % from the previous quarter. Expenses decreased slightly by -46.37 % quarter-on-quarter, aligning with the annual rise of 2300 %. Operating profit, while up 466.67 % compared to last year, faced a quarter-on-quarter increase of 240 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -13.9 %, but an expansion of 4.66 % sequentially. Profit before tax grew annually by 466.67 % but saw an increase from the preceding quarter by 240 %.
Tax expenses as a percentage of profits decreased slightly by -0.97 % compared to last year, with a more notable quarter-on-quarter increase of 10.84 %. Net profit rose by 300 % year-on-year but experienced a 200 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 33.33 % but a quarterly rise of 166.67 %. In summary, Gujarat Inject (Kerala) Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.154 Cr | Rs. 5.419 Cr | Rs. 3.045 Cr | -43.81 % | + 1877.27 % |
| Expenses | Rs. 0.12 Cr | Rs. 5.37 Cr | Rs. 2.88 Cr | -46.37 % | + 2300 % |
| Operating Profit | Rs. 0.03 Cr | Rs. 0.05 Cr | Rs. 0.17 Cr | + 240 % | + 466.67 % |
| Net Profit | Rs. 0.03 Cr | Rs. 0.04 Cr | Rs. 0.12 Cr | + 200 % | + 300 % |
| EPS in Rs | Rs. 0.06 | Rs. 0.03 | Rs. 0.08 | + 166.67 % | + 33.33 % |
In reviewing Gujarat Inject (Kerala) Ltd.’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 1877.27 % year-on-year growth, although there was a slight dip of -43.81 % from the previous quarter. Expenses rose by 2300 % compared to the previous year, with a decrease of -46.37 % quarter-on-quarter. Operating Profit surged by 466.67 % annually, and saw a 240 % increase from the last quarter.
Net Profit showed yearly increase of 300 %, and experienced a 200 % increase from the previous quarter. Earnings Per Share (EPS) rose by 33.33 % annually, however rose by 166.67 % compared to the last quarter. In essence, while Gujarat Inject (Kerala) Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
